Eric Venker is President & COO at Roivant Sciences Ltd. (ROIV). They have made 37 open-market trades across 2 companies since 2022, most recently 2026-10-02.
CIK 0001801917
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ROIV | 1,599,154 | $53.6M |
| IMVT | 257,075 | $6.9M |
| Total | $60.5M |
Shares reported on the most recent Form 4, priced at the 2026-10-05 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMVT | SELL | 2026-10-02 | 2026-10-05 | $34.11 | $120K | -17.1% | — | — |
| ROIV | SELL · 10b5-1 | 2026-09-30 | 2026-10-02 | $36.62 | $7.3M | -6.3% | — | — |
| ROIV | SELL · 10b5-1 | 2026-08-28 | 2026-09-01 | $35.77 | $7.2M | +18.7% | +2.8% | — |
| ROIV | SELL | 2026-07-27 | 2026-07-29 | $34.95 | $7.0M | +7.5% | +4.2% | — |
| IMVT | SELL | 2026-07-02 | 2026-07-06 | $38.48 | $119K | +0.2% | +1.1% | -14.5% |
| ROIV | SELL | 2026-06-24 | 2026-06-26 | $33.16 | $6.6M | +8.7% | +2.4% | +6.7% |
| ROIV | SELL | 2026-05-22 | 2026-05-22 | $30.27 | $6.1M | -1.7% | +4.0% | +22.6% |
| ROIV | SELL | 2026-04-20 | 2026-04-22 | $29.59 | $5.9M | -3.1% | +2.4% | +19.5% |
| IMVT | SELL | 2026-04-02 | 2026-04-03 | $24.10 | $343K | +12.7% | +14.5% | +59.4% |
| ROIV | SELL | 2026-03-17 | 2026-03-19 | $28.24 | $5.6M | -0.0% | +4.9% | +12.6% |
| ROIV | SELL | 2026-02-13 | 2026-02-18 | $26.49 | $5.3M | +3.0% | +1.6% | +3.4% |
| ROIV | SELL | 2026-01-12 | 2026-01-14 | $21.92 | $4.4M | -5.2% | +11.3% | +22.6% |
| ROIV | SELL | 2025-12-23 | 2025-12-29 | $22.47 | $6.2M | +1.5% | +1.2% | +22.0% |
| ROIV | SELL · 10b5-1 | 2025-12-09 | 2025-12-11 | $20.85 | $8.3M | +3.1% | +1.8% | +35.9% |
| ROIV | SELL · 10b5-1 | 2025-11-07 | 2025-11-07 | $20.22 | $4.0M | +0.9% | +4.1% | +4.9% |
| ROIV | SELL · 10b5-1 | 2025-10-15 | 2025-10-17 | $16.99 | $28.9M | +8.4% | +18.8% | +34.6% |
| ROIV | SELL · 10b5-1 | 2025-10-09 | 2025-10-14 | $16.29 | $2.4M | +10.1% | +24.2% | +33.9% |
| ROIV | SELL · 10b5-1 | 2025-10-06 | 2025-10-08 | $16.21 | $21.6M | +10.9% | +28.9% | +35.1% |
| ROIV | SELL · 10b5-1 | 2025-09-19 | 2025-09-23 | $14.93 | $40.5M | +10.4% | +23.7% | +54.8% |
| ROIV | SELL · 10b5-1 | 2025-08-20 | 2025-08-22 | $11.72 | $1.2M | +5.6% | +25.5% | +70.3% |
| ROIV | SELL · 10b5-1 | 2025-07-21 | 2025-07-23 | $11.52 | $1.2M | +1.5% | +5.1% | +57.6% |
| ROIV | SELL · 10b5-1 | 2025-06-20 | 2025-06-24 | $11.45 | $1.1M | -7.7% | -2.2% | +28.4% |
| ROIV | SELL | 2025-06-02 | 2025-06-04 | $11.15 | $22.3M | -1.3% | -4.4% | +10.3% |
| ROIV | SELL · 10b5-1 | 2025-05-20 | 2025-05-22 | $10.95 | $1.1M | +3.5% | +6.2% | +8.2% |
| ROIV | SELL · 10b5-1 | 2025-04-21 | 2025-04-22 | $10.22 | $2.0M | +8.1% | +3.0% | +8.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.